4th Quarter - Report — CORNERSTONE GOVERNMENT AFFAIRS, INC. for VYRIPHARM ENTERPRISES, INC. (2021)

Firm

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Client

VYRIPHARM ENTERPRISES, INC.

Income

$80,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

Lobbyist	Covered position, as disclosed
JOSEPH BISCHOFF	—
TONY ESSALIH	COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS	—

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Health Issues HCR

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

Lobbyist	Covered position, as disclosed
JOSEPH BISCHOFF	—
TONY ESSALIH	COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS	—

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

Lobbyist	Covered position, as disclosed
JOSEPH BISCHOFF	—
TONY ESSALIH	COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS	—

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.